2DRx SOP - LloydsPharmacy

More documents

Recommendations

Info

Associated Risks Pay particular attention when assessing drugs with a narrow therapeutic index and those with potential to cause the greatest harm e.g. Methotrexate and Lithium In addition: • New or unfamiliar drugs • New or unfamiliar customers • Critically ill customers • Drugs with similar names or packaging • Drugs the subject of an NPSA alert Handy Hints Do not rely on your computer system for interaction checks. The CoMPaSS system can be used to check if the patient has had the medication before or if there are any changes to the patient’s medication. Legal guidance can be found in Medicines Ethics and Practice, A Guide for Pharmacists and Pharmacy Technicians. Remember that most computer systems do not alert you to dosage errors. Always check unusual doses in the BNF or other reference material. The pharmacist should check if the patient is taking any other medications, such as OTC products. Keep abreast of developments in therapeutics-CPD. 2DRx Standard Operation Procedure July 2011 Page 12
Interventions and Problem Solving (1) - Prescriber SOP No When will prescriber be available? If unavailable consider discussing with alternative prescriber Inform customer of delay and when query will be resolved. Obtain contact telephone number if appropriate PRESCRIBER Inform customer of the need to contact prescriber without causing undue alarm Prescriber available? Contact prescriber or discuss with customer Decision made based on professional judgement Refer customer to prescriber Record any clinically significant interventions on Intervention & Referral form and annotate CoMPaSS Discuss query with prescriber CUSTOMER (see Customer SOP) Agreement reached with prescriber on appropriate action Record any clinically significant interventions on Intervention & Referral form and annotate CoMPaSS Labelling SOP Communicate outcome to customer 2DRx Standard Operation Procedure July 2011 Page 13 Yes Not dispense No Dispense Yes
Page 1 and 2: 2DRx Standard Operating Procedure T
Page 3 and 4: Refer to pharmacist Return Rx to su
Page 5 and 6: Return to prescriber No Legal requi
Page 7 and 8: 2DRx Standard Operation Procedure J
Page 9 and 10: Associated Risks The prescription m
Page 11: Pharmaceutical Assessment Objective
Page 15 and 16: Interventions and Problem Solving O
Page 17 and 18: Follow Owings SOP No Picking With r
Page 19 and 20: Obtain copy of P.I.L if not availab
Page 21: Detach customer copy when prescript
Page 24 and 25: Owings for Schedule 2 and 3 Control
Page 26 and 27: Associated Risks The picking proces
Page 28 and 29: The electronic endorser must be use
Page 30 and 31: Accuracy Check (1) If the prescript
Page 32 and 33: Accuracy Check Objectives This SOP
Page 34 and 35: Bagging Up Place items in bag, coun
Page 36 and 37: Bagging Up Objectives This SOP is d
Page 38 and 39: Refer to pharmacist if appropriate
Page 40 and 41: Associated Risks Ensure the custome
Page 42 and 43: Process manually in CoMPaSS 2DRx -
Page 44 and 45: If as a result of the review any ch
Page 46 and 47: Accepting a Repeatable Prescription
Page 48 and 49: Processing a Repeatable Prescriptio
Page 50 and 51: • If a customer’s prescription
Page 52 and 53: • The pharmacy / dispensary staff
Page 54 and 55: A5 Customer Record Card for Pharmac
Page 56 and 57: Support Materials From Centurion Pa
Page 58: 2DRx Procedures Employee Declaratio

2DRx SOP - LloydsPharmacy

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?